Royce & Associates’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-499
Closed -$11K 1186
2018
Q2
$11K Buy
499
+274
+122% +$6.04K ﹤0.01% 1193
2018
Q1
$6K Sell
225
-141
-39% -$3.76K ﹤0.01% 1233
2017
Q4
$8K Sell
366
-75
-17% -$1.64K ﹤0.01% 1207
2017
Q3
$8K Buy
+441
New +$8K ﹤0.01% 1188